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Background
Obesity has emerged as major public health problem leading to increased morbidity and
mortality. Epidemiological studies indicate that in many regions of the world, children and
teenagers are increasingly affected by obesity, which contributes for a pessimistic pro-
jection for the near future. Maternal obesity has been implicated in metabolic disorders
of the offspring, but there are no biological markers that can be detected early on life that
predict the development of obesity in the offspring.
Objective
To evaluate the expression of inflammatory markers in the umbilical cord blood of babies
of mothers with obesity/overweight, and correlate these markers with the body weight at
age 9months.
Methods
Anthropometric data of mothers and babies were obtained during prenatal evaluation, at
birth and 9months after birth. Cord blood was collected during delivery of 54 babies from
mothers with obesity/overweight and of 50 babies from lean mothers. Tumour necrosis
factor-alpha (TNF-α), transforming growth factor 1 beta, monocyte chemoattractant
protein-1 and 2 (MCP-1/MCP-2) were determined in serum samples using enzyme-
linked immunosorbent assay methods. Correlations were evaluated using the Spearman
correlation coefficient, and comparisons were evaluated using the non-parametric
Mann–Whitney U-test.
Results
Cord blood TNF-α was positively correlated with maternal body mass index. There was
an inverse correlation between cord blood transforming growth factor 1 beta and baby
body weight at birth. There was no biological marker that predicted body weight at age
9months.
Conclusion
Although we have not found a biological marker to predict increased body weight at
9months of age, the study shows that maternal obesity exposes the baby to higher
TNF-α level in the early stages of life, and this can affect metabolic and inflammatory pa-
rameters during adulthood.
Keywords: Inflammation, obesity, offspring, tumour necrosis factor alpha.© 2016 The Authors
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f the Creative Commons Attribution-NonCommercial License, which permits use, distribution
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a linkbetweenobesityand insulin resistance (1). Studies have
shown that both macrophages present in the adipose tis-
sue, and enlarged adipocytes can produce and secrete
TNF-α, which acts as a paracrine and endocrine signal
to induce insulin resistance in a number of tissues and
cells that depend on insulin in order to control glucose
uptake and metabolism (1–3). Upon binding to its recep-
tor, TNF-α triggers cytosolic inflammatory pathways lead-
ing to the activation of c-Jun Kinase (JNK) and inhibitor of
nuclear Kappa Kinase (IKK) (1,2,4). It has been shown that
both JNK and IKK can catalyse the serine phosphoryla-
tion of the insulin receptor and at least two of its impor-
tant substrates, insulin receptor substrate-1 and insulin
receptor substrate-2, which results in the severe impair-
ment of the insulin signal transduction (4,5). Other studies
have identified additional components of the inflamma-
tory network that connects obesity with insulin resistance
(6–10). Currently, IL-6, IL-1β, PAI-1, TGF-1β and
chemokines, such as MCP-1 and MCP-2, are all known
to play important roles in the inflammatory phenotype of
subjects with obesity (6–10).
Recent studies have shown that maternal obesity can
lead to irreparable injuries in the metabolism of offspring
(11,12). Dunn and Bale demonstrated that feeding preg-
nant rats with a high-fat diet resulted in an increase of
body weight and a reduction of insulin sensitivity in the
offspring and in the next generation (13). Another study
demonstrated that maternal adiposity induces insulin
resistance in the offspring and increased body weight that
persists into adulthood (14). In addition, the induction of
obesity in pregnant rodents result in a number of meta-
bolic abnormalities in the offspring and mechanistic
studies have identified changes in placental morphology,
inflammation and epigenetic factors as important players
in this scenario (11,15,16). Despite the fact that maternal
obesity may increase the risk of obesity and other
metabolic diseases later in life, there is no current method
that allows the prediction of such an outcome. Here, we
hypothesized that inflammatory markers in the cord blood
could correlate with body-weight gain during the first year
of life and, therefore, become useful markers to predict
metabolic diseases in the offspring of mothers with
obesity. In order to test our hypothesis, the levels of
TNF-α, TGF-1β, MCP-1 and MCP-2 were determined in
the cord blood of babies born from mothers with
obesity/overweight or lean mothers and confronted with
a number of clinical and anthropometric parameters from
the mothers and babies, which were followed up for
9months.© 2016 The Authors
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Patient selection and study design
Patients were selected from the obstetric clinic of the
Women’s Health Center at the University of Campinas.
There were 54 patients with overweight/obesity (group 1)
and 50 lean (group 2) included in the study. The inclusion
criteria were pregnant women with obesity/overweight
and appropriate/underweight according to Atalah et al.
(17). The exclusion criteria were pregnancy of twins, use
of steroids during pregnancy, use of non-steroidal anti-
inflammatories, diagnosis of cancer during the 5 years
that preceded pregnancy and diagnosis of any acute or
chronic inflammatory diseases during pregnancy. Imme-
diately after delivery, 2.0mL of blood was collected from
the umbilical cord blood, and serum was prepared and
frozen at 80 °C. The Ethics Committee of the University
of Campinas approved the study (no. 49.775), and all pa-
tients gave informed consent.
Laboratory assessment
The peptides TNF-α (Quantikine-R and D systems, Minne-
apolis, MN, USA), TGF-1β, MCP-1 and MCP-2 (Biolegend
Legend Max, San Diego, CA, USA) were determined in
serum samples using an enzyme-linked immunosorbent
assay method according to the recommendations pro-
vided by the manufacturers.
Anthropometric evaluation
All the anthropometric data from the newborns were
obtained from the medical records at birth and at age
9months. Some babies could not be evaluated at
9months because of discontinued follow-up.
Statistical analysis
Comparisons of blood levels of inflammatory markers
were performed using the non-parametric Mann–Whitney
U-test, whereas the correlations between proteins and
anthropometric parameters were estimated using the
Spearman correlation coefficient. All analyses had a sig-
nificance level of 5%.
Results
The qualitative variables evaluated in the study are pre-
sented in Table 1. There were 61 men and 43 women
newborns. At delivery, 100 newborns were at term
whereas four were pre-term. Regarding the body weight
of mothers at pregnancy detection, there were 29 obese,besity and The Obesity Society. Obesity Science & Practice
Table 1 Qualitative variables evaluated in the study
Variable n = 104 %
Gender
Male 61 58.65
Female 43 41.35
GA at birth
Preterm birth 4 3.85
Postmature birth 100 96.15
Group
Obesity 29 27.88
Overweight 25 24.04
Adequate weight 40 38.46
Underweight 10 9.62
Group
Obesity/Overweight 54 51.92
Adequate weight/Underweight 50 48.08
GA, gestational age.
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mass index values (17). Table 2 depicts the distribution
of mothers according to body mass index and age at
delivery. In addition, Table 2 depicts data of body weight
and body weight variation (from birth to age 9months) in
the babies.
Table 3 presents the concentrations of inflammatory
markers in cord blood comparing samples from groups
1 and 2. TNF-α was significantly higher in the cord blood
of newborns from group 1 mothers. None of the other
peptides were significantly different in the groups.
After 9months, we retrieved data from 78 infants. Table 4
shows the correlation analysis between cord blood in-
flammatory peptide levels and anthropometric parame-
ters of mothers (body mass index and body weight) and
infants (birth weight and weight/BMI at 9months of age).Table 2 Comparison of selected parameters in mothers and babies from
weight/underweight (group 2)
Mother’s BMI Obesity/Overweight
Proper weight/Underweight
Mother’s age Obesity/Overweight
Proper weight/Underweight
Baby’s birth weight Obesity/Overweight
Proper weight/Underweight
Baby’s weight at 9months Obesity/Overweight
Proper weight/Underweight
Baby’s body mass gain Obesity/Overweight
Proper weight/Underweight
BMI, body mass index.
*P value Student’s t-test unpaired
**P value Mann–Whitney U-test
Obesity Science & Practice published by John Wiley & Sons Ltd,The analysis confirmed the existence of a direct correla-
tion between TNF-α concentration in the umbilical cord
blood and maternal body mass index as well as a direct
correlation between TNF-α and body weight of the
mother. The variables body weight and body mass index
of the infants at age 9months did not correlate with the
levels of inflammatory peptides. However, there was an
inverse correlation between the concentration of TGF-1β
and the body weight of newborns at birth, and a trend
towards a positive correlation between TGF-1β and the
body weight of infants at age 9months.
Discussion
In the present study, we evaluated inflammatory markers
in cord blood in a cohort that shares similar characteris-
tics with other cohort previously published {Challier,
2008 #29}. The babies were followed up for 9months be-
cause at this time most, if not all infants were interrupting
breastfeeding. The main objective of the study was to
evaluate the impact of maternal body weight on inflam-
matory parameters of cord blood and its relation with
early body weight gain of babies. We considered that
the longer the period out of breastfeeding the more other
environmental factors could affect the results. First, we
hypothesized that the age of the mothers could influence
inflammatory peptide concentrations in cord blood. In
Table 2, we show the distribution of mothers according
to age. Upon statistical analysis, we detected no correla-
tion between the age of mothers and markers of inflam-
mation in cord blood (data not shown).
Tumour necrosis factor-alpha has been previously
evaluated in the placenta and umbilical cord blood. In a
study with only 15 subjects, Varastehpour and colleagues
(18) evaluated samples from 15 newborns and found adistinct groups: obesity/overweight (group 1) vs. appropriate body
n Mean P
54 34.95 <0.0001**
50 26.09
54 28.04 0.1773**
50 25.98
54 3.35 0.8227*
50 3.33
45 9.29 0.0677*
35 8.67
45 5.94 0.0712*
35 5.34
© 2016 The Authors
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Table 3 Comparisons of the concentrations of inflammatory peptides in the umbilical cord blood between the groups of mothers with obesity/
overweight (group 1) vs. appropriate body weight/underweight (group 2). TNF-α, MCP-1, MCP-2, TGF-1β (pg mL1). Mann–Whitney U-Test
Variable Group n Mean Standard deviation Minimum Median Maximum P
TNF-α Obesity/Overweight 54 4.26 6.07 0.83 2.52 43.37 0.0096
Proper weight/Underweight 48 2.11 1.10 0.25 2.18 4.45
MCP-1 Obesity/Overweight 54 94.86 71.93 21.13 79.28 431.04 0.4051
Proper weight/Underweight 50 111.62 102.63 22.12 84.12 642.65
MCP-2 Obesity/Overweight 54 25.57 11.07 6.54 24.90 71.65 0.3079
Proper weight/Underweight 50 28.00 11.07 7.76 25.35 62.71
TGF-1β Obesity/Overweight 50 179.32 132.20 13.26 150.23 743.69 0.2939
Proper weight/Underweight 48 200.09 120.22 22.22 178.65 429.84
MCP-1, monocyte chemoattractant protein-1; MCP-2, monocyte chemoattractant protein-2; TGF-1β, transforming growth factor-1 beta; TNF-α,
tumor necrosis factor-alpha.
Table 4 Correlations between TNF-α, MCP-1, MCP-2 and TGF-1β in
umbilical cord blood vs. anthropometric parameters of mothers and
babies at birth and at age 9months. Spearman correlation coeffi-
cient, P value and n
TNF-α MCP-1 MCP-2 TGF-1β
Mother’s BMI C 0.2440 0.0584 0.0714 0.0002
P 0.0135 0.5560 0.4713 0.9982
n 102 104 104 98
Mother’s weight C 0.2038 0.0892 0.0948 0.0473
P 0.0399 0.3679 0.3385 0.6441
n 102 104 104 98
Baby’s birth weight C 0.1133 0.1299 0.1300 0.3077
P 03232 0.2507 0.2503 0.0072
n 78 80 80 75
Baby’s weight at
9months
C 0.1800 0.0543 0.0421 0.1343
P 0.1148 0.6325 0.7106 0.2506
n 78 80 80 75
Baby’s BMI C 0.1190 0.0377 0.0392 0.0957
at 9 months P 0.3126 0.7465 0.7366 0.4273
n 74 76 76 71
Weight difference C 0.1620 0.0319 0.0028 0.2086
(9 months vs. birth) P 0.1565 0.7789 0.9805 0.0725
n 78 80 80 75
BMI, body mass index; C, Spearman correlation coefficient; MCP-1,
monocyte chemoattractant protein-1; MCP-2, monocyte chemoattractant
protein-2; n, number; P, P value; TGF-1β, transforming growth factor-
1 beta; TNF-α, tumor necrosis factor-alpha.
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ity. In another study, Challier and colleagues (19) showed
an increased concentration of TNF-α in the placenta of
newborns from mothers with obesity compared with lean
mothers. However, there was no correlation between
inflammatory markers in cord blood and anthropometric
parameters of the newborns. Finally, placental TNF-α
levels correlated positively with maternal adiposity in a
cohort of 60 mothers (20). Similarly to the present data,
there was no correlation between placental TNF-α levels
and newborn body weight at birth (20).© 2016 The Authors
Obesity Science & Practice published by John Wiley & Sons Ltd, World ONo previous studies have measured the concentration
of TGF-1β in umbilical cord blood in children of mothers
with obesity. In our study, we found an inverse correlation
between the weight of the baby at birth and TGF-1β as
well as a tendency towards a positive correlation between
TGF-1β and body weight gain during the first 9months of
life. As babies born with low body weight tend to gain
more weight in the first months of life (21), it is possible
that this positive correlation between TGF-1β and body
weight gain is a simple reflex of this phenomenon. Never-
theless, it is important to emphasize that the findings
regarding TGF-1β are novel, and further studies should
focus on its potential role as a marker of body mass var-
iability during early life.
Finally, we detected no correlation between the
chemokines MCP-1 and MCP-2 and the anthropometric
parameters evaluated in the present study.
Our data confirms that the body weight of mothers
positively impacts the concentration of TNF-α in the cord
blood. Despite the fact that inflammatory peptide levels in
the cord blood had no impact on baby body weight at
birth or at age 9months, it is important to consider that
early exposition to TNF-α may affect metabolic and
inflammatory parameters later in life.
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